This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Loxo Oncology, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Nicolas E S Guisot
Introduction
Nicolas E S Guisot is an accomplished inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Guisot holds a patent for "Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase." This invention relates to compounds of formula (I) that serve as tyrosine kinase inhibitors. Specifically, these compounds are effective in inhibiting Bruton's tyrosine kinase (BTK). The invention also contemplates the use of these compounds for treating various conditions, including cancer, lymphoma, leukemia, and immunological diseases. He has 1 patent to his name.
Career Highlights
Guisot is currently associated with Loxo Oncology, Inc., a company known for its focus on targeted therapies for cancer treatment. His work has contributed to advancements in the understanding and treatment of diseases that involve BTK.
Collaborations
One of his notable coworkers is Mathew Calder, with whom he collaborates on various projects within the company.
Conclusion
Nicolas E S Guisot's innovative work in developing BTK inhibitors showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile